Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
61.36
-0.63 (-1.02%)
At close: Nov 19, 2026, 4:00 PM EST
60.14
-1.22 (-1.99%)
After-hours: Nov 19, 2026, 4:44 PM EST
Eton Pharmaceuticals Revenue
Eton Pharmaceuticals had revenue of $57.93M in the quarter ending September 30, 2026, with 157.91% growth. This brings the company's total for the last twelve months to $141.06M, up 100.61% year-over-year. In the year 2025, Eton Pharmaceuticals had annual revenue of $79.95M with 104.94% growth. That makes Eton Pharmaceuticals the 20,120th largest company in the world by revenue and 3,076th in the United States.
Revenue (ttm)
$141.06M
Revenue Growth
+100.61%
P/S Ratio
12.52
Revenue / Employee
$3,205,932
Employees
44
Market Cap
1.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 79.95M | 40.94M | 104.94% |
| Dec 31, 2024 | 39.01M | 7.37M | 23.29% |
| Dec 31, 2023 | 31.64M | 10.39M | 48.90% |
| Dec 31, 2022 | 21.25M | -581.00K | -2.66% |
| Dec 31, 2021 | 21.83M | 21.79M | 55,879.49% |
| Dec 31, 2020 | 39.00K | -920.00K | -95.93% |
| Dec 31, 2019 | 959.00K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.09B |
| Phibro Animal Health | 1.54B |
| Prestige Consumer Healthcare | 1.17B |
| Trulieve Cannabis | 1.08B |
| ANI Pharmaceuticals | 1.04B |
| BioCryst Pharmaceuticals | 961.51M |
| Amphastar Pharmaceuticals | 745.79M |
| Pacira BioSciences | 743.30M |
ETON News
- 3 days ago - Eton Pharmaceuticals Transcript: Jefferies Global Healthcare Conference - Transcripts
- 9 days ago - Eton Pharmaceuticals price target raised to $81 from $70 at B. Riley - TheFly
- 13 days ago - Eton Pharmaceuticals price target raised to $82 from $78 at Craig-Hallum - TheFly
- 13 days ago - Eton Pharmaceuticals price target raised to $80 from $70 at H.C. Wainwright - TheFly
- 13 days ago - Eton Pharmaceuticals price target raised to $80 from $68 at Canaccord - TheFly
- 14 days ago - Eton Pharmaceuticals reports Q3 EPS 50c, two estimates 37c - TheFly
- 14 days ago - Eton Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - Eton Pharmaceuticals Earnings release: Q3 2026 - Filings